Association between patients' body mass index and emergency department wait times: A multicenter observational cohort investigation by the reducing disparities increasing equity in emergency medicine (REDEEM) study group.

The American Journal of Emergency Medicine
Isabella M LichenAnnie T Sadosty

Abstract

Numerous studies have demonstrated evidence of obesity bias in healthcare settings, however, little is known about obesity bias in the Emergency Department (ED). The objective of this study was to investigate obesity bias in an ED setting by assessing the association between body mass index (BMI) and door-to-room (DTR) or door-to-provider (DTP) times among ED patients. We conducted an observational cohort study of all adult patient (age ≥ 18 years of age) visits to 21 Mayo Clinic and Mayo Clinic Health System EDs between November 1, 2018 and March 31, 2020. We compared DTR and DTP times based on BMI category. We found that median DTR and DTP times for adults with class 3 obesity are significantly shorter than patients in the normal weight category. For men with class 3 obesity, median DTR and DTP times were 7.5% and 5.4% shorter than men in the normal weight category. Relative to women in the normal weight category, the median DTR and DTP times were 4.6% and 3.8% faster for women in obesity class 1, 4.9% and 5.1% faster for women in obesity class 2, and DTR was 4.4% faster for women in obesity class 3. These percentage differences translated to slightly shorter wait times of 0.4-1.2 min compared to median wait times for patient...Continue Reading

References

Apr 8, 1999·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·A Myers, J C Rosen
Oct 24, 2001·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·B A Teachman, K D Brownell
Mar 24, 2005·The New England Journal of Medicine·Samuel H Preston
Mar 24, 2005·The New England Journal of Medicine·S Jay OlshanskyDavid S Ludwig
Aug 5, 2005·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Timothy F Platts-MillsBrandy Snowden
Oct 14, 2005·Obesity Research·Klea D Bertakis, Rahman Azari
Nov 28, 2012·Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine·Tomi MalmströmRaija Malmström
Mar 21, 2013·Obesity·Kimberly A GudzuneLisa A Cooper
Jun 14, 2013·Emergency Medicine Australasia : EMA·Bryan NguiJessica Shill
Jan 27, 2015·Patient Education and Counseling·Michelle S WongSara N Bleich
Mar 11, 2015·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·S M PhelanM van Ryn
May 10, 2017·Annals of Translational Medicine·Mahmoud AbdelaalNeil G Docherty
Aug 29, 2018·Obesity Science & Practice·S M PhelanL J Finney Rutten
Dec 6, 2018·Current Opinion in Endocrinology, Diabetes, and Obesity·Carl J PaladFatima Cody Stanford
Feb 24, 2019·Academic Pediatrics·Elizabeth E HalvorsonJoseph A Skelton
May 24, 2019·Journal of Translational Medicine·Antonino De LorenzoLaura Di Renzo
Jul 25, 2019·Patient Education and Counseling·Jon C TilburtSean Phelan
Nov 11, 2019·Obesity Facts·Angela S AlbergaShelly Russell-Mayhew
Aug 18, 2020·Primary Health Care Research & Development·Angela S AlbergaShelly Russell-Mayhew
Aug 19, 2020·BMC Family Practice·Maria SchwenkeSteffi G Riedel-Heller
Aug 29, 2020·BMC Pregnancy and Childbirth·Angela C Incollingo RodriguezA Janet Tomiyama
Dec 10, 2020·Health Promotion and Chronic Disease Prevention in Canada·Neeru GuptaNatalie Riediger

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.